This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elwell, L P
Right arrow Articles by Rideout, J L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elwell, L P
Right arrow Articles by Rideout, J L

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 February; 31(2): 274-280

Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U).

L P Elwell, R Ferone, G A Freeman, J A Fyfe, J A Hill, P H Ray, C A Richards, S C Singer, V B Knick and J L Rideout

ABSTRACT

The thymidine analog 3'-azido-3'-deoxythymidine (BW A509U; azidothymidine [AZT]) had potent bactericidal activity against many members of the family Enterobacteriaceae, including strains of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Shigella flexneri, and Enterobacter aerogenes. AZT also had bactericidal activity against Vibrio cholerae and the fish pathogen Vibrio anguillarum. AZT had no activity against Pseudomonas aeruginosa, gram-positive bacteria, anaerobic bacteria, Mycobacterium tuberculosis, nontuberculosis mycobacteria, or most fungal pathogens. Several lines of evidence indicated that AZT must be activated to the nucleotide level to inhibit cellular metabolism: AZT was a substrate for E. coli thymidine kinase; spontaneously arising AZT-resistant mutants of E. coli ML-30 and S. typhimurium were deficient in thymidine kinase; and intact E. coli ML-30 cells converted [3H]AZT to its mono-, di-, and triphosphate metabolites. Of the phosphorylated metabolites, AZT-5'-triphosphate was the most potent inhibitor of replicative DNA synthesis in toluene-permeabilized E. coli pol A mutant cells. AZT-treated E. coli cultures grown in minimal medium contained highly elongated cells consistent with the inhibition of DNA synthesis. AZT-triphosphate was a specific DNA chain terminator in the in vitro DNA polymerization reaction catalyzed by the Klenow fragment of E. coli DNA polymerase I. Thus, DNA chain termination may explain the lethal properties of this compound against susceptible microorganisms.


Antimicrob Agents Chemother. 1987 February; 31(2): 274-280




This article has been cited by other articles:

  • Jackson, J. B., Dick, J., Tekle, T., Simmons, A., Carroll, K. C. (2009). Lack of Antimicrobial Activity by the Antiretroviral Drug Nevirapine against Common Bacterial Pathogens. Antimicrob. Agents Chemother. 53: 3606-3607 [Full Text]  
  • Merrikh, H., Ferrazzoli, A. E., Bougdour, A., Olivier-Mason, A., Lovett, S. T. (2009). A DNA damage response in Escherichia coli involving the alternative sigma factor, RpoS. Proc. Natl. Acad. Sci. USA 106: 611-616 [Abstract] [Full Text]  
  • Sandrini, M. P. B., Clausen, A. R., On, S. L. W., Aarestrup, F. M., Munch-Petersen, B., Piskur, J. (2007). Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. J Antimicrob Chemother 60: 510-520 [Abstract] [Full Text]  
  • Sandrini, M. P. B., Shannon, O., Clausen, A. R., Bjorck, L., Piskur, J. (2007). Deoxyribonucleoside Kinases Activate Nucleoside Antibiotics in Severely Pathogenic Bacteria. Antimicrob. Agents Chemother. 51: 2726-2732 [Abstract] [Full Text]  
  • Wang, J., Neuhard, J., Eriksson, S. (1998). An Escherichia coli System Expressing Human Deoxyribonucleoside Salvage Enzymes for Evaluation of Potential Antiproliferative Nucleoside Analogs. Antimicrob. Agents Chemother. 42: 2620-2625 [Abstract] [Full Text]  
  • McLeod, G. X., Hammer, S. M. (1992). Zidovudine: Five Years Later. ANN INTERN MED 117: 487-501 [Abstract]  
  • Packer, S. J., Cesario, T., Williams, J. H. Jr. (1988). Mycobacterium avium Complex Infection Presenting as Endobronchial Lesions in Immunosuppressed Patients. ANN INTERN MED 109: 389-393 [Abstract]